Pharmaceutical company "Petrovax" is responsible for the quality, efficiency and safety of their products. Health of our patients is a high priority for us at "Petrovax". We continuously collect and analyze information regarding safety and efficacy of our products.
In case of adverse events, inefficiency, drug interactions, use during pregnancy or lactation, congenital anomaly, birth defect, drug misuse, overdose, off-label use and new therapeutical effect, please contact in "Petrovax":
You are kindly requested to provide us with the contact details to pharmacovigilance specialist may contact you to clarify missing information and more fully analyze the event.
We assure you that the reported information, including personal data, will be collected strictly confidentially. Only qualified employees in the company and Roszdravnadzor are provided with access to the information.
You can also complete the "Notification of adverse event" directly on the site.